ERAS
ErascaDNasdaq / Pharmaceuticals, Biotechnology & Life Sciences
Last Price
At close
2026-07-22
Current thesis
Primary-source evidence is not purely negative: the April 27 8-K reported dose-dependent PK, broad ctDNA reductions, strong early unconfirmed response rates in NSCLC and PDAC, selected 24 mg and 32 mg as go-forward monotherapy RDEs, and showed early combinability signals, while the 10-K said cash plus January 2026 financing proceeds less the Joyo payment should fund operations into the second half of 2028 [#8-K-2026-04-27] [#10-K-2026-03-12].
Posture
Defensive
Lead driver
Momentum
What changed
Momentum remains the lead driver in the composite, 7D delta +0.3.
What can break
A treatment-related pneumonitis event progressed to Grade 5 after supportive-care withdrawal, creating a real safety overhang around ERAS-0015 [#8-K-2026-04-27].
Momentum
99
Value
41
Sentiment
0
Setup hits (3d)
0 · Net Neutral
AI TargetsBase $8.50 · Bull $13.00 · Bear $5.50
Data freshness
Prices
As of 2026-07-22
Fundamentals
As of 2026-07-22 • Vendor: Data Vendor v1
Scores
As of 2026-07-22 • Model: HYBRID_IC_RP
AI Memo
As of 2026-04-29 • Model: RankAlpha Sentiment Codex
Investment thesisAs of 2026-07-22
Investment thesis
As of 2026-07-22
Supporting evidence
What
Grade D · Defensive
Confidence Medium · Net Neutral
Target $22.55
Why
Momentum99 · Δ7d +0.3
Value41 · Δ7d -0.0
Sentiment0 · Δ7d 0.0
So what
Weak posture (Net Neutral). Prioritize risk control and patience.
Lead driver: Momentum · See technicals
Momentum
99
26% active weight
Current posture
7d trendFlat
Δ7d
+0.3
Δ21d
+1.5
Value
41
39% active weight
Current posture
7d trendFlat
Δ7d
-0.0
Δ21d
-0.1
Sentiment
0
34% active weight
Current posture
7d trendFlat
Δ7d
0.0
Δ21d
0.0
Why this grade
Composite grade D. Momentum 99.3 / Value 41.1 / Sentiment 0.0
Fundamentals (TTM)As of 2026-07-22
Fundamentals (TTM)
As of 2026-07-22
Market Cap
$6.77B
Beta
1.15
Shares Out
347.13M
P/E (TTM) · Derived
-44.4
P/S (TTM)
-
P/FCF (TTM) · Derived
-61.82
Rev YoY
-
EPS YoY
+451.5%
Gross Margin
-
Op Margin
-
Net Debt
-$228.94M
Current Ratio
9.52
As of 2026-07-22 • Updated nightlySource: Internal modelMethodology